ab1903 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab1903 は 18 報の論文で使用されています。

  • Guo YJ  et al. Resveratrol alleviates MPTP-induced motor impairments and pathological changes by autophagic degradation of a-synuclein via SIRT1-deacetylated LC3. Mol Nutr Food Res 60:2161-2175 (2016). PubMed: 27296520
  • Wu F  et al. Rotenone impairs autophagic flux and lysosomal functions in Parkinson's disease. Neuroscience 284:900-11 (2015). PubMed: 25446361
  • Meli G  et al. Conformational targeting of intracellular Aß oligomers demonstrates their pathological oligomerization inside the endoplasmic reticulum. Nat Commun 5:3867 (2014). PubMed: 24861166
  • Sagi Y  et al. Nitric oxide regulates synaptic transmission between spiny projection neurons. Proc Natl Acad Sci U S A 111:17636-41 (2014). PubMed: 25413364
  • Amschl D  et al. Time course and progression of wild type a-synuclein accumulation in a transgenic mouse model. BMC Neurosci 14:6 (2013). ICC/IF ; Human . PubMed: 23302418
  • Tomás-Zapico C  et al. a-Synuclein accumulates in huntingtin inclusions but forms independent filaments and its deficiency attenuates early phenotype in a mouse model of Huntington's disease. Hum Mol Genet 21:495-510 (2012). Mouse . PubMed: 22045698
  • Powers BE  et al. Axonal thinning and extensive remyelination without chronic demyelination in spinal injured rats. J Neurosci 32:5120-5 (2012). PubMed: 22496557
  • Yanamandra K  et al. a-Synuclein Reactive Antibodies as Diagnostic Biomarkers in Blood Sera of Parkinson's Disease Patients. PLoS One 6:e18513 (2011). WB ; Human . PubMed: 21541339
  • Mulcahy P  et al. Characterisation of a novel model of Parkinson's disease by intra-striatal infusion of the pesticide rotenone. Neuroscience 181:234-42 (2011). PubMed: 21277943
  • Herzig MC  et al. LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice. Hum Mol Genet 20:4209-23 (2011). IHC-P ; Mouse . PubMed: 21828077
  • Candela P  et al. Apical-to-basolateral transport of amyloid-ß peptides through blood-brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by P-glycoprotein. J Alzheimers Dis 22:849-59 (2010). WB, ICC ; Rat . PubMed: 20858979
  • Chaves RS  et al. Protein aggregation containing beta-amyloid, alpha-synuclein and hyperphosphorylated tau in cultured cells of hippocampus, substantia nigra and locus coeruleus after rotenone exposure. BMC Neurosci 11:144 (2010). WB, ICC ; Rat . PubMed: 21067569
  • Su B  et al. Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease. Mol Neurodegener 4:32 (2009). IHC-P ; Human . PubMed: 19627592
  • Westerlund M  et al. Cerebellar {alpha}-synuclein levels are decreased in Parkinson's disease and do not correlate with SNCA polymorphisms associated with disease in a Swedish material. FASEB J : (2008). PubMed: 18606870
  • Ekstrand MI  et al. Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons. Proc Natl Acad Sci U S A 104:1325-30 (2007). IHC-FoFr ; Mouse . PubMed: 17227870
  • Li X  et al. Leucine-rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson's disease R1441C/G mutants. J Neurochem 103:238-47 (2007). PubMed: 17623048
  • Austin SA  et al. Alpha-synuclein expression modulates microglial activation phenotype. J Neurosci 26:10558-63 (2006). WB ; Mouse . PubMed: 17035541
  • Castagnet PI  et al. Fatty acid incorporation is decreased in astrocytes cultured from alpha-synuclein gene-ablated mice. J Neurochem 94:839-49 (2005). WB ; Mouse . PubMed: 16033426

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"